Dr. David Stein, M.D

NPI: 1740386341
Total Payments
$209,598
2024 Payments
$27,696
Companies
26
Transactions
1,425
Medicare Patients
176
Medicare Billing
$67,060

Payment Breakdown by Category

Other$156,271 (74.6%)
Food & Beverage$31,044 (14.8%)
Travel$18,313 (8.7%)
Education$3,550 (1.7%)
Consulting$420.00 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $156,271 78 74.6%
Food and Beverage $31,044 1,224 14.8%
Travel and Lodging $18,313 106 8.7%
Education $3,550 15 1.7%
Consulting Fee $420.00 2 0.2%

Top Paying Companies

Company Total Records Latest Year
Alkermes, Inc. $67,066 203 $0 (2024)
ABBVIE INC. $44,611 145 $0 (2024)
Otsuka America Pharmaceutical, Inc. $37,422 121 $0 (2024)
Allergan, Inc. $16,842 70 $0 (2020)
Takeda Pharmaceuticals America, Inc. $13,590 43 $0 (2017)
Takeda Pharmaceuticals U.S.A., Inc. $13,441 208 $0 (2024)
Sunovion Pharmaceuticals Inc. $4,109 226 $0 (2022)
Neurocrine Biosciences, Inc. $2,731 60 $0 (2024)
Teva Pharmaceuticals USA, Inc. $2,195 70 $0 (2024)
Janssen Pharmaceuticals, Inc $1,542 52 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $27,696 206 Alkermes, Inc. ($18,550)
2023 $44,437 212 AbbVie Inc. ($26,264)
2022 $27,917 227 Alkermes, Inc. ($20,589)
2021 $23,661 225 Alkermes, Inc. ($10,970)
2020 $7,071 127 Allergan, Inc. ($2,839)
2019 $20,281 120 Otsuka America Pharmaceutical, Inc. ($11,825)
2018 $28,947 137 Otsuka America Pharmaceutical, Inc. ($10,564)
2017 $29,587 171 Takeda Pharmaceuticals America, Inc. ($13,590)

All Payment Transactions

1,425 individual payment records from CMS Open Payments — Page 1 of 57

Date Company Product Nature Form Amount Type
12/27/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage In-kind items and services $29.40 General
Category: SCHIZOPHRENIA
12/20/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $6.65 General
Category: NEUROSCIENCE
12/19/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $19.14 General
Category: Neuropsychiatry
12/18/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $24.36 General
Category: CNS
12/17/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $26.94 General
Category: NEUROSCIENCE
12/17/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $2.45 General
Category: CNS
12/13/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $12.94 General
Category: PSYCHIATRY
12/10/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $27.88 General
Category: Psychology/Psychiatric
12/09/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $18.22 General
Category: Psychiatry/Psychology
12/05/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $34.99 General
Category: PSYCHIATRY
12/04/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $14.68 General
Category: CNS
12/04/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $10.10 General
Category: NEUROSCIENCE
12/03/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $23.12 General
Category: Neuropsychiatry
11/27/2024 Alkermes, Inc. LYBALVI (Drug), LYBALVI, LYBALVI Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $760.00 General
Category: CNS
11/26/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $22.29 General
Category: Central Nervous System
11/21/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $10.84 General
Category: PSYCHIATRY
11/20/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $5.14 General
Category: CNS
11/19/2024 Alkermes, Inc. LYBALVI (Drug), LYBALVI, LYBALVI Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,060.00 General
Category: CNS
11/19/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage In-kind items and services $37.99 General
Category: SCHIZOPHRENIA
11/19/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $26.91 General
Category: NEUROSCIENCE
11/14/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $28.90 General
Category: Central Nervous System
11/14/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $10.48 General
Category: NEUROSCIENCE
11/14/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $1.18 General
Category: NEUROSCIENCE
11/13/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $35.00 General
Category: PSYCHIATRY
11/12/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $28.06 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 1 31 243 $36,450 $15,318
2022 1 30 278 $41,700 $18,585
2021 2 53 263 $40,060 $16,911
2020 2 62 336 $52,130 $16,247
Total Patients
176
Total Services
1,120
Medicare Billing
$67,060
Procedure Codes
6

All Medicare Procedures & Services

6 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 31 243 $36,450 $15,318 42.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 30 278 $41,700 $18,585 44.6%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 29 205 $30,780 $14,946 48.6%
90832 Psychotherapy, 30 minutes Office 2021 24 58 $9,280 $1,964 21.2%
90832 Psychotherapy, 30 minutes Office 2020 29 173 $27,680 $9,087 32.8%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 33 163 $24,450 $7,160 29.3%

About Dr. David Stein, M.D

Dr. David Stein, M.D is a Psychiatry healthcare provider based in Honolulu, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740386341.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Stein, M.D has received a total of $209,598 in payments from pharmaceutical and medical device companies, with $27,696 received in 2024. These payments were reported across 1,425 transactions from 26 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($156,271).

As a Medicare-enrolled provider, Stein has provided services to 176 Medicare beneficiaries, totaling 1,120 services with total Medicare billing of $67,060. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Other Specialties Child & Adolescent Psychiatry
  • Location Honolulu, HI
  • Active Since 09/15/2006
  • Last Updated 10/06/2011
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • NPI Number 1740386341

Products in Payments

  • LYBALVI (Drug) $64,214
  • VRAYLAR (Drug) $61,341
  • REXULTI (Drug) $38,358
  • Trintellix (Drug) $21,849
  • LATUDA (Drug) $4,109
  • INGREZZA (Drug) $2,731
  • CAPLYTA (Drug) $2,139
  • ARISTADA (Drug) $1,873
  • INVEGA SUSTENNA (Drug) $1,419
  • TRINTELLIX (Drug) $1,395
  • AUSTEDO (Drug) $1,297
  • Aristada 441 mg (Drug) $828.80
  • ABILIFY MAINTENA (Drug) $557.00
  • UZEDY (Drug) $463.66
  • Austedo XR (Drug) $434.39
  • SPRAVATO (Drug) $318.12
  • Auvelity (Drug) $291.48
  • BRINTELLIX (Drug) $228.10
  • Dayvigo (Drug) $224.07
  • VYVANSE (Drug) $203.11

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Honolulu